Saffron for PMS and Menstrual Symptoms
Premenstrual syndrome (PMS) mixes physical symptoms — bloating, breast tenderness, cramps, fatigue — with emotional ones like irritability, low mood, and tearfulness in the days before a period. Because saffron has the best-documented mood effect of any culinary herb, it is a natural candidate for the emotional side of PMS, and a landmark double-blind trial found it did reduce premenstrual symptoms more than placebo. There is also early evidence for menstrual cramps (dysmenorrhea). This page presents that research fairly: the mood evidence for saffron is strong, but the number of trials done specifically for PMS and menstrual pain is still small, so the honest verdict is "promising and biologically sensible," not "proven first-line treatment."
Table of Contents
- PMS and PMDD: What They Are
- Saffron's Actives and the Mood-Hormone Link
- The Landmark Saffron PMS Trial
- How Saffron May Ease Premenstrual Symptoms
- Saffron and Menstrual Cramps
- The Mood Overlap: PMDD and Premenstrual Depression
- Saffron Among Herbal Options for PMS
- How Saffron Was Used in the Trials
- Cautions (Especially Pregnancy)
- Key Research Papers
- Connections
- Featured Videos
PMS and PMDD: What They Are
Premenstrual syndrome (PMS) refers to a cluster of physical and emotional symptoms that appear in the luteal phase — the roughly two weeks between ovulation and the start of a period — and reliably ease once bleeding begins. Most people who menstruate notice some premenstrual changes; PMS is diagnosed when those changes are troublesome enough to interfere with daily life.
A more severe, mood-dominated form is premenstrual dysphoric disorder (PMDD), in which intense irritability, depression, anxiety, and a sense of being overwhelmed dominate the premenstrual window and substantially disrupt relationships and work. PMDD is classified as a depressive disorder, which is precisely why a compound with antidepressant activity — like saffron — is a plausible thing to study for it. The emotional symptoms of PMS and PMDD, more than the physical ones, are where saffron's known biology is most likely to help.
Saffron's Actives and the Mood-Hormone Link
Saffron's three key compounds — the carotenoid pigments crocin and crocetin and the aroma molecule safranal — are the same actives behind its antidepressant effects. The leading explanation for a premenstrual benefit is therefore an extension of the mood story: premenstrual mood symptoms are thought to arise partly from the brain's sensitivity to the natural fall in progesterone and its calming metabolite allopregnanolone in the late luteal phase, together with shifts in serotonin signaling.
Serotonin is central here. Selective serotonin reuptake inhibitors (SSRIs) are a first-line medical treatment for PMDD, and they can work within days rather than the weeks needed for depression — suggesting the serotonin system is the key lever premenstrually. Because saffron compounds appear to modestly support serotonin activity and reduce oxidative and inflammatory stress, they act on plausibly the right pathway. This is a mechanistic rationale, not a proven mechanism, but it is a coherent one.
The Landmark Saffron PMS Trial
The cornerstone study is Agha-Hosseini and colleagues (2008), published in BJOG: An International Journal of Obstetrics and Gynaecology — a respected mainstream journal, which is notable for a herbal trial.
The researchers enrolled women aged 20 to 45 with regular cycles and PMS and randomized them to saffron 30 mg per day (15 mg twice daily) or an identical placebo for two menstrual cycles. Symptoms were tracked with the Premenstrual Daily Symptoms questionnaire and, for mood specifically, the Hamilton Depression Rating Scale. The result was clear: a significantly greater proportion of women in the saffron group achieved a meaningful reduction in premenstrual symptoms (defined as at least a 50 percent drop in symptom scores) compared with the placebo group, and their depression scores fell further as well.
This was still a modest trial by pharmaceutical standards — a few dozen women over two cycles — but its double-blind, placebo-controlled design and publication in a leading obstetrics journal make it a genuinely useful data point rather than an anecdote. The dose it used, 30 mg per day, is the same one that recurs throughout saffron's depression research, which makes the findings easy to connect.
How Saffron May Ease Premenstrual Symptoms
Putting the mechanisms together, saffron could plausibly help premenstrual symptoms through several routes at once:
- Mood stabilization via modest support of serotonin, dopamine, and norepinephrine activity — the emotional core of PMS and PMDD.
- Reduced irritability and tension, consistent with saffron's documented effects on low mood and mild anxiety in non-menstrual settings.
- Anti-inflammatory and antioxidant effects, which may bear on the physical malaise, breast tenderness, and fatigue that accompany the luteal phase.
What the evidence does not establish is a hormonal effect — there is no good evidence that saffron changes estrogen or progesterone levels, and its benefit is better understood as acting on how the brain responds to normal hormonal shifts rather than on the hormones themselves.
Saffron and Menstrual Cramps
Dysmenorrhea — painful menstrual cramps caused largely by prostaglandin-driven uterine contractions — is a separate problem from PMS, though the two often coexist. Saffron has appeared in this research mainly as part of multi-herb formulas. Nahid and colleagues (2009), in the Journal of Midwifery & Women's Health, tested an Iranian herbal preparation combining saffron, celery seed, and anise against a conventional anti-inflammatory painkiller for primary dysmenorrhea and found the herbal formula reduced pain.
The trial had three arms and was randomized, double-blind and placebo-controlled: 180 female students aged 18 to 27 received the herbal capsule, the painkiller mefenamic acid, or a placebo. The herbal group took 500 mg of saffron, celery seed and anise extracts three times a day for three days, starting when bleeding or pain began. Both the herbal capsule and mefenamic acid relieved menstrual pain compared with placebo, and the drop in pain scores was significantly greater with the herbal capsule than with mefenamic acid.
Because saffron was one ingredient among several, this trial cannot isolate saffron's specific contribution to pain relief — a real limitation. It suggests saffron-containing formulas may help with cramps, but it does not prove saffron alone is an effective analgesic. For cramps specifically, the physical mechanisms (relaxing uterine muscle, lowering prostaglandins) are less obviously saffron's strength than its mood effects are.
The Mood Overlap: PMDD and Premenstrual Depression
The strongest logical case for saffron in the menstrual context is the overlap between premenstrual mood symptoms and the depression and anxiety that saffron is best proven to help. PMDD is formally a depressive disorder, and premenstrual worsening of an existing mood or anxiety condition is common. The large body of saffron mood research — including systematic reviews and meta-analyses covering depression, anxiety, and general mood, and trials of standardized extracts in people with low mood — is therefore indirectly relevant here.
The reasonable interpretation is that saffron's well-supported mood benefit is likely to carry over to the emotional symptoms of PMS and PMDD, while acknowledging that few trials have tested this directly in a premenstrual population. That is a fair, evidence-based position: strong general mood data, limited PMS-specific data, and a coherent reason to expect the two to connect.
Saffron has since been tested directly in PMDD. In a 2020 randomized controlled trial from Isfahan, Iran (Rajabi and colleagues), 120 women diagnosed with PMDD took fluoxetine (20 mg twice daily), saffron (15 mg twice daily) or a placebo for 2 weeks in the luteal phase of two menstrual cycles. All three groups improved; on the daily symptom record saffron did significantly better than placebo (P = 0.027), while depression scores on the Hamilton scale did not differ among the three groups. Fluoxetine caused significantly more side effects than the other two.
Saffron Among Herbal Options for PMS
Saffron is one of several botanicals studied for premenstrual symptoms. Dante and Facchinetti (2011) reviewed herbal treatments for PMS and PMDD and concluded that a handful — most notably chasteberry (Vitex agnus-castus), along with saffron and others — had randomized evidence of benefit, while many popular remedies did not. Placing saffron in that context is useful: it is among the better-supported herbal options for PMS, not a lone outlier, but the overall herbal evidence base for PMS remains modest and heterogeneous.
The numbers behind that review: of 102 articles identified, 17 randomized trials were eligible and 10 were included. Chasteberry was the most studied remedy (four trials, about 500 women) and was reported to ease PMS more than placebo consistently; single trials supported either ginkgo or saffron; evening primrose oil and St John's wort showed no effect different from placebo. The authors noted that too few women had been tested for firm conclusions on safety.
A 2026 meta-analysis of randomized trials (Mohammadi and Karimi) pooled the saffron studies and found a significant reduction in PMS symptoms (standardized mean difference −0.64; 95% confidence interval −0.84 to −0.44) and in menstrual pain (standardized mean difference −0.51; 95% confidence interval −1.01 to −0.01). For menstrual pain the upper end of that interval sits just below zero.
For the emotional symptoms, saffron's mood pedigree arguably gives it an edge over herbs studied mainly for physical complaints; for cramps and bloating, other approaches may be more directly targeted. Many people combine approaches — for example pairing a mood-focused option with magnesium and vitamin B6, both of which have their own PMS evidence.
How Saffron Was Used in the Trials
- Dose: the PMS trial used 30 mg per day of saffron in capsules (15 mg twice daily), the same dose as the depression studies — a convenient consistency.
- Timing: in the landmark trial saffron was taken daily across the whole cycle for two cycles, not only in the premenstrual window. The effect was judged over two full cycles; premenstrual symptoms vary from month to month.
- Form: the trials used capsules; culinary threads vary in potency, and the amounts used in cooking fall far below the studied dose.
- Symptom tracking: the trials measured the effect with a daily symptom record kept across cycles; the placebo response in PMS is substantial.
Severe premenstrual symptoms and PMDD have effective prescription treatments; selective serotonin reuptake inhibitors are a first-line medical treatment for PMDD. In the trials above, saffron was compared with placebo and, in the PMDD trial, with fluoxetine.
Cautions (Especially Pregnancy)
- Pregnancy and medicinal doses. This is the most important caution for anyone in their reproductive years. High doses of saffron have traditionally been used to stimulate the uterus and menstruation, and are considered potentially unsafe in pregnancy. The concern applies to anyone who could become pregnant or is trying to conceive. Culinary pinches in food are not the concern; concentrated 30 mg supplements are. See the sources and safety page.
- Serotonergic overlap. Saffron is thought to act on serotonin, so its effect could add to that of a selective serotonin reuptake inhibitor (a common PMDD treatment) or another serotonergic medication. This concern comes from how saffron is thought to work.
- Dose range. The trials used 30 mg/day; high doses of saffron are reported to be toxic, not more effective.
- Other causes. Severe cyclical mood symptoms are the mark of PMDD, and very heavy or irregular bleeding or disabling pain can have medical causes, such as fibroids or endometriosis, that are diagnosed by examination.
Key Research Papers
- Agha-Hosseini M, Kashani L, Aleyaseen A, et al. (2008). Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG — PubMed PMID: 18271889
- Nahid K, Fariborz M, Ataolah G, Solokian S (2009). The effect of an Iranian herbal drug on primary dysmenorrhea: a clinical controlled trial. Journal of Midwifery & Women's Health — PubMed PMID: 19720342
- Dante G, Facchinetti F (2011). Herbal treatments for alleviating premenstrual symptoms: a systematic review. Journal of Psychosomatic Obstetrics & Gynaecology — PubMed PMID: 21171936
- Lopresti AL, Drummond PD, Inarejos-García AM, Prodanov M (2018). affron, a standardised extract from saffron for the treatment of youth anxiety and depressive symptoms: a randomised, double-blind, placebo-controlled study. Journal of Affective Disorders — PubMed PMID: 29510352
- Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al. (2005). Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytotherapy Research — PubMed PMID: 15852492
- Lopresti AL, Drummond PD (2014). Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology — PubMed PMID: 25384672
- Hausenblas HA, Saha D, Dubyak PJ, Anton SD (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine — PubMed PMID: 24299602
- Mahmoudi R, et al. (2026). Effect of saffron on depression, anxiety and mood disorder: a GRADE-assessed systematic review and meta-analysis of 34 randomized controlled trials. Nutritional Neuroscience — PubMed PMID: 41693488
- Cerdá-Bernad D, Costa L, Serra AT, et al. (2022). Saffron against Neuro-Cognitive Disorders: An Overview of Its Main Bioactive Compounds, Their Metabolic Fate and Potential Mechanisms of Neurological Protection. Nutrients — PubMed PMID: 36558528
- Matraszek-Gawron R, Chwil M, Terlecki K, Skoczylas MM (2022). Current knowledge of the antidepressant activity of chemical compounds from Crocus sativus L. Pharmaceuticals — PubMed PMID: 36678554
- Rajabi F, Rahimi M, Sharbafchizadeh MR, Tarrahi MJ (2020). Saffron for the Management of Premenstrual Dysphoric Disorder: A Randomized Controlled Trial. Advanced Biomedical Research — PubMed PMID: 33457343
- Mohammadi MM, Karimi Z (2026). Effect of saffron on premenstrual syndrome and dysmenorrhea: a systematic review and meta-analysis. Korean Journal of Family Medicine — PubMed PMID: 41151539